Search results
Found 30060 matches for
Professor of Matrix Biology Kim Midwood, of the Kennedy Institute of Rheumatology, NDORMS has been named in the BioBeat 2015 Movers and Shakers report.
UCB-Translational Pharmacology Scholarship
Applications for this project will open soon.
Norman Collisson Foundation Scholarship
Applications for this project are now closed.
Themes
OCTRU runs trials across multiple areas of medicine. Within OCTRU there are five core therapeutic areas of expertise, although trials are also undertaken outside of these areas and groups.
Related profile
-
Kim Midwood
Kennedy Director of Graduate Studies
Find out more about
Similar stories
TCRs drive CARs
1 May 2025
Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer treatments. This study, published in Cell, demonstrates that engineering T-cells to express both a Chimeric Antigen Receptor (CAR) and a T-cell Receptor (TCR) can improve their ability to distinguish between cancerous and healthy tissues—addressing a major challenge in current immunotherapy.